Biomarkers are needed to improve the diagnosis of neuropsychiatric disorders. 20
Introduction
defined two groups; maturity-marker genes and immaturity-marker genes that are inducible by 105 neural hyperexcitation. We assessed the expression patterns of these two groups of 106 maturation-related genes in 80 public gene-expression datasets derived from the postmortem 107 brains of patients with various neuropsychiatric disorders and from neural cells derived from 108 patient iPSCs, and in a further 12 datasets from the brains of related animal models. Through 109 this analysis, we characterized the expression patterns of maturation-related genes that are 110 inducible by neural hyperexcitation across different disease conditions. 111 (932 words) 112
Neural hyperexcitation induces immature-like gene expression patterns in DG 116
To examine the developmental changes in gene expression patterns in the rodent DG, 117 we created a microarray dataset from postnatal day 8, 11, 14, 17, 21, 25, and 29 infant mice 118 (GSE113727) and compared it with a dataset from 33-week-old adult mice (GSE42778) 12 . 119 Within the entire mice DG dataset, the largest overlap for changes in gene expression after 120 pilocarpine injection was for the comparison between day 8 infant and 33-week-old adult mice 121 ( Figure S1a ). We included the dataset from postnatal day 8 infant mice for subsequent analysis. 122
The expression levels of 6552 genes were increased in the DG of infant mice compared with 123 adult mice, whereas the expression levels of 8637 genes were decreased (absolute fold change 124 > 1.2 and t-test P < 0.05). Next, we assessed the changes in gene expression induced by neural 125 hyperexcitation in a rodent model. We obtained publicly available microarray datasets from the 126 DG of adult rats after seizures induced by injection of pilocarpine (GSE47752) 47 . The 127 expression levels of 7073 genes were significantly changed in the DG of epileptic-seizure rats 128 1 day after pilocarpine injection compared with rats treated with saline (absolute fold change > 129 obtained publicly available microarray datasets for the human fetal hippocampus during development (GSE25219) 48 . Within the entire fetal hippocampal dataset, the largest overlap for 150 changes in gene expression after pilocarpine injection was for the comparison between 151 8-9-week fetuses and 19-23-week fetuses ( Figure S1b ). We again found a striking degree of 152 similarity: 2043 genes showed changes in expression in both datasets (overlap P = 1.8 × 10 −12 ) 153 ( Figure 1b ). Among these 2043 genes, we termed the 579 genes whose expression decreased in 154 both datasets "hiM genes (human)" (green bar in Figure 1b ) and the 716 genes whose 155 expression increased in both datasets "hiI genes (human)" (red bar in Figure 1b ). The overlap 156 for genes with positively correlated expression (red and green bars) were larger than those with 157 negatively correlated expression (light and dark yellow bars), suggesting that, similar to the 158 results in mice, the gene expression changes in rat DG after seizure induction are comparable to 159 the reverse of the changes that occur as the human hippocampus develops. 160 161
Hyperexcitation-induced maturity-and immaturity-related genes exhibit different biological 162
properties 163
To characterize the biological features associated with the hiM and hiI gene groups in 164 mouse and human, we conducted pathway enrichment analyses in BaseSpace. The 20 165 biogroups with the most significant overlap with hiM and hiI genes are listed in Table 1a and 166 1b. Among mouse hiM genes, 4 out of the top 20 biogroups are associated with synapse and 167 channel activity (e.g., transmission of nerve impulse, synapse, and synaptic transmission) 168 (Table 1a ), whereas among human hiM genes, 6 out of the top 20 biogroups are also associated 169 with synapse and channel activity (e.g., transmission of nerve impulse, synaptic transmission, 170 axon, and synapse) (Table 1b) . 171
Among the mouse hiI genes, 4 out of the top 20 biogroups were associated with the 172 nucleus (e.g., genes involved in the cell cycle and genes involved in DNA replication) ( Table  173 1a). Among the human hiI genes, 15 out of the top 20 biogroups were associated with the 174 nucleus (e.g., genes involved in the cell cycle, chromosomes, and response to DNA damage 175 stimulus) (Table 1b ). It is noteworthy that there is little overlap in the top 20 biogroups for the 176 hiM and hiI genes (Table 1a, 1b) . Thus, the biogroups related to the hiM and hiI genes are 177 likely to be functionally different. 178
We also compared datasets from the DG of typically developing infants with datasets 179 from rat DG at three different timepoints after seizure induction by injection of pilocarpine or 180 kainite (day 1, day 3, and day 10) ,and performed principal component analysis on the changes 181 in mouse hiM/hiI genes at different timepoints (Figure S2a, S2b; Supplementary Results). The 182 time-course of changes in the mouse hiM genes after seizure induction was different from the time-course of changes in the mouse hiI genes. In addition, we conducted a spatial pattern 184 analysis of the mouse hiM/hiI genes, which indicated that their protein products have slightly 185 different patterns of subcellular localization ( Figure S2c ; Supplementary Results). The mouse 186 hiM genes tend to be strongly expressed at the plasma membrane, with expression changes 187 stabilizing by the third day after seizure induction. By contrast, the hiI genes tend to be 188 expressed in the nucleus and changes in expression after seizure induction are slower to 189 stabilize. Together, these results indicate that the hiM/hiI genes have different spatiotemporal 190 patterns of changes in expression. 191
192

Gene expression patterns in patients can be characterized in terms of hiM/hiI genes 193
Next, we investigated whether and to what extent the expression changes in 194 maturation-related genes induced by hyperexcitation overlap with gene expression patterns in 195 various neuropsychiatric disorders. As above, we evaluated similarities between the changes in 196 gene expression patterns in different groups using overlap P-values calculated by Running 197 Fisher algorithm (Figure 2a ). Similarity indexes for each comparison were defined as the −log 198 of the overlap P-values with hiM or hiI genes, denoted by hiM-index or hiI-index, respectively. 199
High values in hiM-/hiI-index represent that there is large overlap between the dataset analyzed 200 and hiM/hiI genes. We obtained the hiM-/hiI-indexes for the datasets from human patients and 201 plotted them in two-dimensional (2-D) space to show the extent of overlap between datasets 202 and hiM/hiI genes (Figure 2a ). 203
We initially performed this 2-D analysis on a dataset containing the expression 204 profile of the prefrontal cortex in the postmortem brains of patients with schizophrenia 205 (schizophrenia dataset #1: details in Table S2 ) ( Figure 2b ). The expression of 1744 genes 206 differed between patients and healthy controls (significance level of 0.05). The numbers of hiM 207 and hiI genes with altered expression in schizophrenia dataset #1 were 87 and 76, respectively, 208 and the overlap P-values were 2.4 × 10 −10 and 6.9 × 10 −7 . The hiM-index and hiI-index for this 209 dataset were 9.62 (= −log(2.4×10 −10 )) and 6.16 (= −log(6.9×10 −7 )). This result corresponds to a 210 point in 2-D space (Figure 2b Huntington's disease (HD), and major depressive disorder (MDD); Table S2 ). Results of each 223 dataset are shown in Figure 3b Thus, the 2-D analysis revealed that some neuropsychiatric diseases have 233 characteristic patterns in the hiM-/hiI-indexes: for example, most datasets from patients with 234 schizophrenia exhibited a higher hiM-index than hiI-index, whereas ALS datasets showed 235 hiI-index-dominant pattern ( Figure 3i ). Meanwhile, different diseases sometimes show similar 236 changes in the hiM-or hiI-index; for example, some of the schizophrenia, ASD, and AD 237 datasets shared a high hiM-index, and some of the ALS, and AD datasets shared a high 238 hiI-index. The other four diseases-PD, BPD, HD, and MDD-did not show pronounced 239 changes in hiM-/hiI-indexes, suggesting that these diseases may not share endophenotype as 240 pseudoimmaturity inducible by neural hyperexcitation. These results raise the possibility that 241 there are patterns of gene-expression perturbations that are shared and distinct across these 242 neuropsychiatric disorders. 243 244
Genetic and environmental risk factors induce changes in the pattern of expression of 245 hiM/hiI genes 246
Previous studies suggest that many genetic risk and environmental factors, such as 247 seizure, hypoxia, and infection, contribute to the development of neuropsychiatric 248 disorders 2,49,50 . We next applied the 2-D analysis technique to datasets from genetic animal 249 models of disorders and from animals that experienced risk events. 250
First, we obtained publicly available datasets for mice that had experienced putative 251 risk events for schizophrenia, bipolar disorders, and Alzheimer's disease, including seizure the hiM-and hiI-indexes to reveal the short-and long-term effect of risk event on expression 256 patterns of hiM/hiI genes. The results showed that datasets from mouse hippocampus treated 257 with kainite, seizure-inducing drug, exhibited time-course changes in the hiM-and hiI-indexes: 258 the hiM-index tended to be dominant in the early stage after seizure induction, and the 259 hiI-index became more dominant in the late stages ( Figure 4a Next, we obtained datasets from animal models with a genetic risk of a 267 neurodegenerative disease: mice with transgenic expression of a G93A mutant form of human 268 SOD1, as a model of ALS (#1: GSE46298, #2: GSE18597) 55,56 ; transgenic mice with mutant 269 human amyloid precursor protein (APP) and presenilin1 (PSEN1) genes, which cause familial 270
Alzheimer's disease (#1: GSE64398, #2: GSE64398) 57 ; and Df16(A) heterozygous mice 271 carrying a chromosome 16 deletion syntenic to human 22q11.2 microdeletions, as a model of 272 schizophrenia (GSE29767) 58 . We also obtained datasets from Schnurri-2 (Shn-2) knockout 273 mice as a model of schizophrenia 12 and intellectual disability 14,59,60 and from mice with 274 heterozygous knockout of the alpha-isoform of calcium/calmodulin-dependent protein kinase 275 II (alpha-CaMKII+/−) 10,13 as a model of bipolar disorder. We performed 2-D analysis on these 276 datasets and evaluated the changes in the hiM-/hiI-indexes of these model mice. Both datasets 277 from transgenic mice with a SOD1(G93A) mutation exhibited a higher hiI-index than 278 hiM-index in the later stages of disease progression (Figure 4b ). These hiI-index-dominant 279 patterns were also observed in the results derived from human patients with ALS ( Figure 3b ). 280
In the mice with mutant human APP and PSEN1, both the hiM-and hiI-indexes increased in 281 dataset from hippocampus and only hiI-index increased in dataset from cortex during the 282 course of disease progression (Figure 4c ). These patterns are neutral or hiI-index-dominant. 283
These patterns partially mimic the results from human patients with Alzheimer's disease 284 ( Figure 3c ). The Df16(A) heterozygous mice and alpha-CaMKII+/− mice showed 285 hiM-index-dominant patterns, which are similar to results from human patients with 286 schizophrenia (Figure 4d ). Shn-2 KO mice showed high values for both the hiM-and extent consistent with the results from human patients, indicating that these model mice share 289 similar patterns of pseudoimmaturity induced by neural hyperexcitation with those of human 290 patients. 291 (2236 words) 292
In this study, we demonstrated that neural hyperexcitation induces changes in the 295 pattern of gene expression in the DG that are significantly similar to the immature 296 hippocampus of typically developing human fetuses. From the pool of genes, we identified two 297 groups of genes, and found that these are shared by multiple neuropsychiatric disorders, such 298 as schizophrenia, Alzheimer disorders, and ALS. 299
Many of the datasets from patients with schizophrenia and from the postmortem 300 brains of patients with Alzheimer's disease exhibited hiM-index-dominant pattern changes. 301
The hiM genes include a GABA receptor, voltage-dependent calcium channel, glutamate 302 receptor, and voltage-dependent sodium channel (Table S1 ). These genes have been reported to 303 be implicated in the pathological changes in the brains of patients with schizophrenia and 304
Alzheimer's disease 61-64 . Thus, many of the synaptic genes that changed in the brains of 305 patients with schizophrenia or Alzheimer's disease could be genes whose expression increases 306 during maturation and decreases with neural hyperexcitation. Although reductions in the 307 expression of some synaptic genes in these disorders are well documented, our results are the 308 first to raise the possibility that neuronal hyperexcitation may also induce reductions in such 309 synaptic molecules. 310
Most of the datasets from patients with ALS and Alzheimer's disease exhibited 311 hiI-index-dominant patterns. The hiI genes include DNA methyltransferase, cyclin, 312 cyclin-dependent kinase, integrin beta 3 binding protein, and tumor protein p53 (Table S1) . 313
These genes are known to be important in chromosomal modification and DNA repair, and 314 abnormal functions of these systems have been observed in patients with ALS and Alzheimer's 315 disease 65-69 . Thus, some of the genes that are considered to be important in the development of 316 these disorders are immaturity-related genes, whose expressions decrease during maturation 317 and can be increased by neural hyperexcitation. 318
As for the datasets from patients with PD, BPD, HD, and MDD, most of them did not 319 show significant overlap either hiM or hiI genes, indicating that there might not be pathological 320 changes of pseudoimmaturity inducible by neural hyperexcitation in the datasets of these four 321 diseases. Thus, we suggest that gene expression analysis based on the findings derived from 322 shared endophenotypes are helpful to conduct transdiagnostic characterization of 323 neuropsychiatric disorders. 324
Our study has some limitations. First, the number of available datasets was limited. 325
All the datasets except the one for mouse development were obtained from the BaseSpace 326 Correlation Engine. On this platform, vast numbers (over 21,000) of complex biological and our keyword query to avoid sampling bias, the number of datasets was still small, from 8 329 datasets for ALS to 16 datasets for schizophrenia. Further accumulation of the studies will 330 improve the reliability of our results. Another limitation is that the datasets used in this study 331 are from different types of sample, including various central nervous system areas, such as the 332 hippocampus, prefrontal cortex, striatum, and the spinal cord. The gene expression 333 abnormalities in patients could differ depending on the brain area 48 . We also used datasets from 334 cultured neurons differentiated from the iPSCs of human subjects, and it is controversial 335 whether the pattern of gene expression in these neurons is comparable with that of neurons in 336 the patients' brains 70, 71 . It is also possible that the altered gene expression in the postmortem 337 brains is due to the effects of medication rather than pathological changes from the disease 338 itself 72 . Other conditions that were not controlled in this study include the age at death, storage 339 conditions of the samples, genetic background of animals, and animal housing conditions. For 340 these reasons, we need to be careful in interpreting the results of the analyses. It is noteworthy, 341 however, that despite the variety of sample types used, we were able to identify some shared 342 and distinct patterns of gene expression. (C57BL/6J × BALB/cA background; n = 5) 73 , and microarray experiments were performed as 366 previously described 10 . The microarray data, including those used in this study, were deposited 367 in the GEO database under accession number GSE113727. We also obtained a dataset for 368 33-week-old wild-type mice, which we previously reported (C57BL/6J × BALB/cA 369 background) (GSE42778) 12 . We integrated these two datasets into one to construct the dataset 370 for the development of wild-type mouse DG used in this study (P8 versus adult, fold change > 371 1.2, P < 0.05). 372 373
Data collection and processing 374
Except for the mouse DG developmental dataset mentioned above, the 91 gene 375 expression datasets used in this study were obtained from publicly available databases (listed 376 in Table S2 ). All gene expression datasets were analyzed with the BaseSpace Correlation 377 histograms (after statistical testing) with false-discovery rate analysis to establish whether the 385 number of significantly altered genes is larger than that expected by chance. Other microarray 386 data processing was performed in MAS5 (Affymetrix, Santa Clara, CA, USA) 44 . 387
Genes with a P-value < 0.05 (without correction for multiple testing) and an absolute 388 fold change > 1.2 were included in the differentially expressed gene datasets. This sensitivity 389 threshold is typically the lowest used with commercial microarray platforms and the default 390 criterion in BaseSpace analyses 44 . All data from the Affymetrix GeneChip series were 391 downloaded from the NCBI GEO database. Affymetrix Expression Console software 392 (specifically the robust multiarray average algorithm) was used to preprocess the data. 393
We used the expression values (on a log base-2 scale) to calculate the fold changes 394 and P-values between two conditions (infants-adults and patients-healthy controls). To divided by those of the control data sets. If the fold change was < 1.0, these values were 397 converted into the negative reciprocal or −1/(fold change). Genes with an absolute fold change 398 > 1.2 and a t-test P-value < 0.05 were imported into BSCE according to the instructions 399 provided by the manufacturer. The rank order of these genes was determined by their absolute 400 fold change. We compared the signatures in two given gene sets using BSCE. All statistical 401 analyses were performed in BaseSpace and similarities between any two datasets were 402 evaluated as overlap P-values using the Running Fisher algorithm 44 
